Therefore, we can conclude that DNMT3A primarily regulates the senescence program in RMS, with its silencing increasing p16 and p21 expression and promoting cellular senescence, while DNMT3B is more directly linked to DNA damage responses and repair, and its silencing leads to impaired DNA repair and enhanced radiosensitivity across multiple cancer types. The gene discussed is DNMT3A; the disease is cancer.